U.S. Water Utilities Stock News

KE Holdings was recently added to the Hang Seng China Enterprises Index, while institutions highlighted the company's planned cost optimization in its core property transaction operations for 2026. This combination of benchmark index inclusion and an efficiency push in its real estate platform could meaningfully reshape how investors assess its earnings quality and business mix. Next, we will examine how KE Holdings’ Hang Seng China Enterprises Index inclusion may influence its existing...

In late February 2026, nLIGHT, Inc. reported fourth-quarter 2025 revenue of US$81.19 million and a net loss of US$4.91 million, capping a full-year revenue of US$261.33 million and a net loss of US$23.47 million, while also issuing first-quarter 2026 revenue guidance of US$70 million to US$76 million. The company underscored strong aerospace and defense growth, plans to exit lower-margin cutting and welding markets, and over US$190 million of new equity capital earmarked for manufacturing...

DNOW (DNOW) just reported fourth quarter and full year 2025 results that combined higher sales with a swing to net loss, along with an update that its previously announced share repurchase program is now completed. See our latest analysis for DNOW. At a share price of US$11.78, DNOW’s recent 7 day share price return of an 11% decline and 30 day share price return of a 22% decline suggest fading momentum after the earnings driven swing from profit to loss. This is also reflected in its 1 year...

Recent reports of labor shortages affecting Puerto Rico, the U.S., the Virgin Islands, and other markets have pushed First BanCorp (FBP) into focus as investors reassess its credit and operational risk profile. See our latest analysis for First BanCorp. The latest labor shortage headlines arrive after a sharp 4.8% one day share price decline and a 7.0% 7 day share price return. However, First BanCorp’s 1 year total shareholder return of 12.4% and 5 year total shareholder return of 124.8%...

In February 2026, Supernus Pharmaceuticals reported fourth-quarter 2025 revenue of US$211.57 million and record full-year 2025 revenue of US$718.95 million, but swung to a full-year net loss of US$38.55 million and guided 2026 operating earnings to a range of US$0–US$30 million on expected total revenues of US$840–US$870 million. The results highlighted strong contributions from newer CNS products such as Qelbree, GOCOVRI, ZURZUVAE, and newly approved ONAPGO, alongside the completed Sage...

Penske Automotive Group (PAG) has been trading in a relatively tight range, with a modest move over the past month and a slight decline over the past 3 months, prompting fresh interest in its valuation. See our latest analysis for Penske Automotive Group. While the share price has eased in the past week and quarter, the roughly flat year to date share price return sits alongside a 5 year total shareholder return of 127.95%, suggesting longer term holders have still seen strong compounding. If...

Why Jefferies Stock Is Back Under Pressure Jefferies Financial Group (JEF) is back in focus after a hotter than expected US Producer Price Index report and fresh concerns around Market Financial Solutions, where Jefferies is among the backers. The PPI surprise has weighed on rate cut hopes, while questions over a potential collateral shortfall at the UK mortgage lender have added another overhang for Jefferies shares. See our latest analysis for Jefferies Financial Group. Those inflation...

Pool Corporation (NasdaqGS:POOL) is highlighting its resilience in a tough pool industry backdrop, with flat revenues and weakness in new pool construction. The company is leaning on pricing discipline, supply chain initiatives, and digital efforts to support gross margins and customer service. Ongoing acquisition activity remains part of Pool's growth playbook as it looks to expand its reach and capabilities. Pool, a major distributor of swimming pool supplies, equipment, and related...

In late February 2026, Thryv Holdings filed an US$8.15 million shelf registration for 2,179,185 common shares tied to its ESOP and reported fourth-quarter 2025 results showing quarterly sales of US$191.62 million, a net loss of US$9.66 million, and full-year 2025 sales of US$785.02 million with net income of US$0.31 million. Beyond the headline figures, the results underscored Thryv’s rapid pivot toward higher-margin SaaS and AI-powered tools, with SaaS revenue rising sharply, margins...

Option Care Health, Inc. recently reported its fourth-quarter and full-year 2025 results, with Q4 sales rising to US$1,465.45 million while net income eased slightly to US$58.5 million, and full-year sales increasing to US$5.65 billion alongside modestly higher earnings per share from continuing operations. Alongside these results, the company reaffirmed its 2026 outlook and expanded its share repurchase authorization to US$1 billion, highlighting management’s focus on capital returns even...

In the fourth quarter and full year 2025, Acadia Healthcare reported higher revenue but swung to a net loss after recording a very large, non-cash goodwill impairment charge of US$996.2 million and issuing 2026 revenue guidance of US$3.37 billion to US$3.45 billion with flat to 1% same-facility volume growth. Management is pivoting from rapid bed expansion to sharpening operational performance at newer facilities, while also managing pressure from New York Medicaid policy changes that are...

GDS Holdings (NasdaqGM:GDS) has drawn attention after recent share price swings, with a 1 day decline of 1.1% and an 8.4% drop over the past week reshaping short term sentiment. See our latest analysis for GDS Holdings. The recent 1 day and 1 week share price declines come after a stronger 90 day share price return of 21.61% and a 1 year total shareholder return of 8.57%. This may hint at cooling momentum following a solid rebound phase. If GDS Holdings has you thinking about where...

First Hawaiian, Inc. recently filed its 2025 10-K, detailing a shift to two core segments, Retail Banking and Commercial Banking, alongside US$129.9 million in dividends and US$100.0 million in share repurchases, reinforcing its current capital allocation priorities. The combination of segment realignment and sizeable capital returns highlights how management is repositioning the bank’s business mix while returning excess capital to shareholders. Next, we’ll examine how the new Retail and...

In February 2026, CBIZ, Inc. reported fourth-quarter 2025 results showing sales of US$542.66 million and a net loss of US$79.42 million, alongside full-year 2025 sales of US$2.76 billion and net income of US$115.44 million, and issued 2026 revenue guidance of US$2.8 billion to US$2.9 billion while expanding its share repurchase activity. Beneath the strong headline growth driven by acquisitions such as Marcum, investors focused on weak organic expansion, margin pressure, and cautious 2026...

Arrowhead Pharmaceuticals (ARWR) is back in focus as investors react to progress in its RNA interference drug pipeline, including two therapies in Phase 3 trials and multiple partnerships with large pharmaceutical partners. See our latest analysis for Arrowhead Pharmaceuticals. The recent excitement around Arrowhead’s RNAi pipeline and partnerships comes after a choppy few weeks for the stock, with a 1 month share price return of an 8.74% decline but a 90 day share price return of 12.48%...

In late February 2026, PROCEPT BioRobotics reported Q4 2025 results showing sales rising to US$76.38 million but a wider quarterly net loss of US$29.85 million, alongside resetting 2026 revenue guidance to US$390 million–US$410 million and issuing new 2027 targets that include 25%–30% revenue growth and a 68%–70% gross margin. While the company pointed to record procedure volumes, stronger handpiece pricing and a path toward improved margins, investors also had to weigh a larger loss profile...

Expeditors International of Washington (EXPD) is back in focus after pairing its full year 2025 earnings release with a new US$3b share repurchase authorization, a combination that directly affects capital returns and investor sentiment. See our latest analysis for Expeditors International of Washington. The latest news lands after a choppy few weeks for the stock, with a 7 day share price return of a 7.21% decline and a 30 day share price return of a 9.66% decline. Even so, the 1 year total...

In February 2026, Nomad Foods reported fourth-quarter 2025 results showing sales of €773.1 million versus €793.4 million a year earlier and a net loss of €10.7 million, while completing a €348.46 million buyback that retired 21,397,779 shares, or 13.85% of its share count under a program launched in 2023. Management framed 2026 as a transition year with planned price increases, especially in Fish, and organizational restructuring that are expected to pressure near-term organic sales and...

Capital Southwest Corporation recently declared monthly regular dividends of US$0.1934 per share for April, May, and June 2026, and a supplemental dividend of US$0.06 per share for the June quarter, with record and ex-dividend dates aligned on April 15, May 15, and June 15, and payments running through June 30, 2026. These combined regular and supplemental payouts, supported by a dividend reinvestment plan tied to taxable income estimates, underscore the company’s emphasis on recurring cash...

Fortrea Holdings (FTRE) shares came under pressure after the contract research group reported fourth quarter 2025 results with revenue and adjusted earnings below analyst forecasts, along with full year 2025 and 2026 guidance that trailed market expectations. See our latest analysis for Fortrea Holdings. At a share price of US$10.72, Fortrea has recorded a sharp 30 day share price return of a 37.13% decline and a 1 year total shareholder return of a 22.60% loss. This suggests momentum has...

In late February 2026, F.N.B. Corporation faced pressure alongside other banks after hotter-than-expected US producer inflation data and growing credit risk concerns reduced investors’ confidence in rate-cut prospects and the sector’s loan quality. At the same time, F.N.B. was named to TIME’s list of America’s Best Financial Services 2026 and collected 14 Crisil Coalition Greenwich Best Bank Awards, underscoring its reputation for client-focused commercial banking despite these...

Encompass Health has recently declared a quarterly cash dividend of US$0.19 per share, payable on April 15, 2026, and confirmed senior leadership participation in the March 2026 Barclays Global Healthcare Conference, while also earning placement on Fortune’s 2026 World’s Most Admired Companies and Forbes’ 2026 America’s Best Companies lists. This combination of steady capital returns, visible investor outreach, and repeated recognition for corporate quality highlights how the company is...

Melco Resorts & Entertainment (MLCO) just picked up fresh ESG recognition, securing a place in the S&P Global Sustainability Yearbook 2026 with a 96th percentile industry ranking and an improved CDP Water score. See our latest analysis for Melco Resorts & Entertainment. That ESG recognition arrives at a tricky point for the stock, with the share price at US$5.94 after a roughly 37% 3 month share price decline and a 1 year total shareholder return of about 7%. Recent momentum looks weak even...

In February 2026, Henry Schein reported fourth-quarter 2025 results showing sales of US$3,437 million and net income of US$101 million, alongside a US$15 million intangible asset impairment charge. These results capped a year of higher sales and earnings per share, supported by strong contributions from equipment, specialty products, technology businesses, and ongoing share repurchases totaling about US$2.97 billion since 2018. Given this combination of robust quarterly revenue growth and...